JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND 1-DAY ACUVUE TRUEYE (NARA A); LENSES, SOFT CONTACT, DAILY WEAR
|
Back to Search Results |
|
Catalog Number 1D4 |
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problems
Corneal Ulcer (1796); Discomfort (2330)
|
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).(b)(6).
|
|
Event Description
|
On 21aug2017 our affiliate in (b)(4) received an email from an eye care provider (ecp) who diagnosed a patient (pt) with a corneal ulcer while wearing the 1 day acuvue trueye brand contact lenses.A call was placed to the ecp who reported he/she wanted to change the pts power from -4.00 to -4.25.No additional medical information was provided in the call.On 21aug2017 a call was placed to the pt and additional information was provided: pt reported he/she felt a discomfort while wearing the suspect lens initially.The pt reported visits to the ecp on (b)(6) 2017, but pt could not provide the event date.The pt reported he/she was diagnosed with a corneal ulcer in the right eye; pt reports the ecp advised the pt ¿it was a side effect of wearing contact lenses¿.The pt was prescribed 3 eye drops; opieye vigamox: to use every 2 hours, ocuflox to use before bed; pt reported he/she does not wear lenses every day.Pt reported the suspect contact lens was discarded.On 31aug2017 an email was received from the pt with the medical report.Additional medical information was provided as follows: ¿marginal cornea ulcer on (b)(6) 2017; idiopathic corneal ulcer on (b)(6) 2017 ¿ pt went to 2 different hospitals.Prescription: optima drop (eye inflammation) every 2 hrs; ocuflox oint (eye inflammation) to right eye before bedtime; mungmun ocufloxacin tb (microbial infection); dexifen tb (antipyretic-analgesic); vegamox 0.5 drops (eye inflammation) every 2 hours; hyaluronic drops (dryeye) frequently; verase tb (antiinflamm-antiphlogistic); recostar tb (for peptic ulcer)¿.On 05sep2017 an email was sent to the affiliate for clarification of the 2 corneal ulcer diagnoses received: marginal cornea ulcer on (b)(6) 2017; idiopathic corneal ulcer on (b)(6) 2017.Per the affiliate, the pt reported the first treating ecp advised him/her to see a specialist.On 13sep2017 a call was placed to the pt to see if the corneal ulcer event had resolved, but no further information was received.The date of event is reported as (b)(6) 2017.No additional medical information has been received.A lot history review was performed for lot 5440740107: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot 5440740107 was produced under normal conditions.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|
|
Manufacturer Narrative
|
On file review, it was noted that the (b)(6) 2017 follow-up phone call information from the pt was mistakenly omitted from the initial submission: pt reported that (b)(6) 2017 was the last visit to the ecp and pt will send the medical report; pt reported that the eye seemed to be fine; pt reported the ecp advised the pt that the corneal ulcer is healed, but the pt should not return to lens wear for about 2 months; pt reported he/she is still using the eye drops prescribed with same dosage.On (b)(6) 2017 a follow-up call was placed to the pt to check the condition of the right eye.The pt provide the additional information as follows: the pt reported he/she will be going to the eye care provider (ecp) again next week.Pt reports the treatment frequency has not changed and pt is still using the eye drops as previously reported.The pt has not yet returned to contact lens wear.The pt is currently wearing glasses.On (b)(6) 2017 a follow-up phone call was placed to the pt for additional medical information, but no additional information was received.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|
|
Search Alerts/Recalls
|
|
|